Save

Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review

In: Beneficial Microbes
Authors:
P. Roman Department of Nursing Science, Physiotherapy and Medicine, Universidad de Almería, Ctra. Sacramento s/n, 04120 Almería, Spain.
Department of Nursing, Universitat Jaume I, Castellón, Spain. Avenida de Vicent Sos Baynat, s/n, 12071 Castellón de la Plana, Spain.

Search for other papers by P. Roman in
Current site
Google Scholar
PubMed
Close
,
F. Carrillo-Trabalón Faculty of Health Sciences, Universidad de Almería, Ctra. Sacramento s/n, 04120 Almería, Spain.

Search for other papers by F. Carrillo-Trabalón in
Current site
Google Scholar
PubMed
Close
,
N. Sánchez-Labraca Department of Nursing Science, Physiotherapy and Medicine, Universidad de Almería, Ctra. Sacramento s/n, 04120 Almería, Spain.

Search for other papers by N. Sánchez-Labraca in
Current site
Google Scholar
PubMed
Close
,
F. Cañadas Department of Psychology, Universidad de Almería, Ctra. Sacramento s/n, 04120 Almería, Spain.

Search for other papers by F. Cañadas in
Current site
Google Scholar
PubMed
Close
,
A.F. Estévez Department of Psychology, Universidad de Almería, Ctra. Sacramento s/n, 04120 Almería, Spain.

Search for other papers by A.F. Estévez in
Current site
Google Scholar
PubMed
Close
, and
D. Cardona Department of Nursing Science, Physiotherapy and Medicine, Universidad de Almería, Ctra. Sacramento s/n, 04120 Almería, Spain.

Search for other papers by D. Cardona in
Current site
Google Scholar
PubMed
Close
Download Citation Get Permissions

Access options

Get access to the full article by using one of the access options below.

Institutional Login

Log in with Open Athens, Shibboleth, or your institutional credentials

Login via Institution

Purchase

Buy instant access (PDF download and unlimited online access):

$40.00

Evidence suggests that the gut microbiota might play an important role in fibromyalgia syndrome (FMS) and chronic fatigue syndrome (CFS). Our goal is to systematically review the reported effect of probiotic treatments in patients diagnosed with FMS or CFS. A systematic review was carried out using 14 databases (PubMed, Cochrane Library, Scopus, PsycINFO, and others) in February 2016 to search for randomised controlled trials (RCTs) and pilot studies of CFS or FMS patient, published in the last ten years (from 2006 to 2016). The Jadad scale was used to asseverate the quality of the clinical trials considered. Two studies (n=83) met the inclusion criteria, which were performed in CFS patients and both studies were considered as a ‘High range of quality score’. The administration of Lactobacillus casei strain Shirota in CFS patients, over the course of 8 weeks, reduced anxiety scores. Likewise, this probiotic changed the faecal composition following 8 weeks of treatment. Additionally, the treatment with Bifidobacterium infantis 35624 in CFS patients, during the same period, reduced inflammatory biomarkers. The evidence about the usefulness of probiotics in CFS and FMS patients remains limited. The studied strains of probiotics have demonstrated a significant effect on modulating the anxiety and inflammatory processes in CFS patients. However, more experimental research, focusing mainly on the symptoms of the pathologies studied, is needed.

Content Metrics

All Time Past 365 days Past 30 Days
Abstract Views 1216 978 193
Full Text Views 27 17 3
PDF Views & Downloads 46 35 7